Summary
? Mix&Go? is a proven and commercialised technology
? Mix&Go? now targeting an established IVD (pathology) market
? Mix&Go? being tested by healthcare companies in multiple sectors - pathology
(IVD), research, point of care, diagnostics, immunoprecipitation, R&D
? Over 60 leading healthcare companies currently testing and assessing the
technology ? not one has said no
? Mix&Go? has multiple applications outside of healthcare
? ADO well funded with $7.0 million in cash ? potential to access current market
opportunities with current cash position
Short term value drivers
Research & Development: Currently 2-3 healthcare R&D companies actively
considering Mix&Go? - short term revenue
opportunities as R&D companies take less time on
approval processes
Major global IVD Players: ADO is currently working on supply agreements
with leading global IVD players
Life sciences market: ADO actively pursuing possible supply agreement
with leading global life sciences company
Add to My Watchlist
What is My Watchlist?
